Semaglutide's once-weekly injection schedule became the standard in clinical practice after the SUSTAIN trials demonstrated consistent weight loss and metabolic improvements on this regimen
Perturbations in the resulting lists were grouped into 11 classes: Biotic stress (Bs), Chemicals (Che), Germination (Ge), Light (Li), N-starvation (-N), Fe-deficiency (-Fe), Salt stress (Sa), Hypoxia (Hy), Drought (Dr), Heat (He), and Cold (Co)
Regarding participant characteristics, the majority of studies enrolled overweight or obese adults with type 2 diabetes, or those receiving glucose-lowering treatments such as metformin, SGLT2 inhibitors, DPP-4 inhibitors, or insulin
Join thousands of members who have already achieved 15-20% weight loss on average